首页|祛浊清源汤联合雷公藤多苷佐治糖尿病肾病临床研究

祛浊清源汤联合雷公藤多苷佐治糖尿病肾病临床研究

扫码查看
目的 探讨祛浊清源汤联合雷公藤多苷佐治糖尿病肾病(DN)的临床疗效。方法 选取医院 2021 年 6 月至 2023 年 6 月收治的DN患者 120 例,按随机数字表法分为对照组和观察组,各 60 例。两组患者均予饮食控制、降血糖、利尿消肿、控制血压、调节血脂等基础治疗,并于餐后口服雷公藤多苷片;观察组患者加用祛浊清源汤治疗。两组均以 8 周为 1 个疗程,均持续治疗 3 个疗程。结果 观察组总有效率为 91。67%,显著高于对照组的 75。00%(P<0。05)。治疗后,观察组患者的中医证候积分(包括气短乏力、五心烦热、腰膝酸软、下肢浮肿等项目)均显著低于对照组(P<0。05);β2-微球蛋白、尿素氮、血清肌酐水平均显著低于对照组(P<0。05);微管相关蛋白 1 轻链 3-Ⅱ、核因子κB、NOD样受体热蛋白结构域相关蛋白 3 表达水平均显著低于对照组(P<0。05)。两组患者治疗后的不良反应发生率及丙氨酸氨基转移酶水平和白细胞计数均相当(P>0。05)。结论 祛浊清源汤联合雷公藤多苷佐治DN,可进一步改善患者的中医证候及肾功能,降低炎性因子水平。
Clinical Study of Quzhuo Qingyuan Decoction Combined with Tripterygium Glycosides in the Adjuvant Treatment of Diabetic Nephropathy
Objective To investigate the clinical efficacy of Quzhuo Qingyuan Decoction combined with tripterygium glycoside in the adjuvant treatment of diabetic nephropathy(DN).Methods A total of 120 patients with DN admitted to the hospital from June 2021 to June 2023 were selected and divided into the control group and the observation group by the random number table method,with 60 cases in each group.The patients in the two groups were given basic treatments(diet control,glucose lowering,diuresis,diminution of swelling,blood-pressure control,blood-lipid regulation)and Tripterygium Glycoside Tablets orally after meals,on this basis,the patients in the observation group were treated with Quzhuo Qingyuan Decoction.Both groups were continuously treated for three courses with eight weeks as a course.Results The total effective rate in the observation group was 91.67%,which was significantly higher than 75.00%in the control group(P<0.05).After treatment,the traditional Chinese medicine(TCM)syndrome(including shortness of breath,fatigue,dysphoria with feverish sensation in chest,palms and soles,soreness and weakness of the waist and knees,lower limb edema)scores in the observation group were significantly lower than those in the control group(P<0.05);β2-microglobulin(β2-MG),blood urea nitrogen(BUN)and serum creatinine(SCr)levels were significantly lower than those in the control group(P<0.05);microtubule-associated protein 1 light chain 3(LC3-Ⅱ),nuclear factor-κB(NF-κB),NOD-like receptor thermal protein domain associated protein 3(NLRP3)expression levels were significantly lower than those in the control group(P<0.05).The incidence of adverse reactions,alanine aminotransferase(ALT)level and white blood cell count(WBC)were similar between the two groups after treatment(P>0.05).Conclusion Quzhuo Qingyuan Decoction combined with Tripterygium Glycoside Tablets in the adjuvant treatment of DN can improve the TCM syndrome,renal function,and reduce the inflammatory factors levels of patients.

diabetic nephropathyQuzhuo Qingyuan Decoctiontripterygium glycosideclinical efficacytraditional Chinese medicine syndromerenal function indexinflammatory factor

史红星、高福顺、张静、王鑫、陈立祥

展开 >

河北省衡水市中医医院,河北 衡水 053000

糖尿病肾病 祛浊清源汤 雷公藤多苷 临床疗效 中医证候 肾功能指标 炎性因子

河北省中医药管理局科研计划项目

2020534

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(2)
  • 18